PARKINSONISM - ONSET PROGRESSION AND MORTALITY
PARKINSONISM - ONSET PROGRESSION AND MORTALITY
复制标题
DOI:
10.1212/wnl.17.5.427
复制
发表时间:
1967-01-01
期刊:
影响因子:
9.9
通讯作者:
YAHR, MD
中科院分区:
文献类型:
--
作者:
HOEHN, MM;YAHR, MD
A practical classification of the types of parkinsonism (primary, secondary, and indeterminate) was presented along with a system for grading severity into 5 stages. The natural history of the syndrome of parkinsonism was studied in 802 patients followed in the Vanderbilt Clinic during the period 1949 to 1964. Two-thirds of all patients with primary parkinsonism have their onset of illness between the ages of 50 and 69 which was the same in men and women. The gradual shift to an older age distribution in recent years is discussed. Approximately one-quarter of the patients with Parkinson''s disease who had their disease for less than 5 years were already severely disabled or dead. By 5 to 9 years this had increased to two-thirds and by 10 to 14 years'' duration, to over 80%. Among patients with primary parkinsonism there is a small group of atypical patients who, with slow evolution of the disease process, maintain balance and righting reflexes for 10 or more years and are not severely disabled for 20 or more years. There were no definitely significant correlations among sex of the patient, age at onset of the disease, severe infections or other events preceding the onset of parkinsonism, positive family history of parkinsonism or other neurological disease, and the rate of progression of the disease. Tremor is most frequently the initial symptom. There is some indication that, at least during the 1st 10 years of illness, parkinsonism with tremor as the initial symptom progresses more slowly than parkinsonism with other symptoms. Parkinsonism shortens life substantially, regardless of the age at onset or the type of parkinsonism. The observed mortality is 3 times that of the general population of the same age, sex, and color. The relative mortality risk is less for men than women and less for those in whom tremor was the initial symptom rather than rigidity, bradykinesia, or other non-tremor manifestation. There is no evidence that the introduction of newer methods of medical treatment and supportive care has substantially prolonged life. For patients treated surgically, follow-ups are not yet sufficiently long to indicate a trend. Bronchopneumonia and urinary infections are causes of death more frequently in parkinsonian patients of all ages than they are in the general population. In certain age and sex groups of parkinsonian patients there are also more deaths due to accidental injury, peptic ulcer, and vascular lesions of the central nervous system. There is no evidence that patients with parkinsonism are in any way resistant to malignant neoplastic disease.